氨甲环酸预防自发性蛛网膜下腔出血复发
Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.
作者信息
Gelmers H J
出版信息
Acta Neurochir (Wien). 1980;52(1-2):45-50. doi: 10.1007/BF01400945.
PMID:7376944
Abstract
Tranexamic acid as an antifibrinolytic agent has been investigated in a controlled study in patients with recent subarachnoid haemorrhage. It is concluded that tranexamic acid improves neither rebleeding rates, nor mortality. Predominantly thrombotic complications have been noted as a more serious side effect of tranexamic acid.
摘要
在一项针对近期蛛网膜下腔出血患者的对照研究中，对氨甲环酸作为一种抗纤溶药物进行了调查。得出的结论是，氨甲环酸既不能降低再出血率，也不能降低死亡率。已注意到主要的血栓形成并发症是氨甲环酸更严重的副作用。
Zotero 插件